말초동맥 질환 시장 규모, 점유율, 성장 분석 : 유형별, 치료법별, 질환별, 투여 경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Peripheral Artery Disease Market size was valued at USD 5.85 Billion in 2024 and is poised to grow from USD 6.46 Billion in 2025 to USD 14.25 Billion by 2033, growing at a CAGR of 10.4% during the forecast period (2026-2033).

Market insights reveal that around 6.5 million individuals aged 40 and older in the U.S. are impacted by Peripheral Artery Disease (PAD), affecting both genders with a notably higher incidence among African Americans. The aging population plays a critical role in the growing prevalence of PAD, as the risk of vascular diseases increases with age. Furthermore, the demographic shift is paralleled by a rise in innovations and approvals for diagnostics and treatment solutions for PAD. These elements converge to enhance the overall risk landscape for peripheral arterial disease. The combination of an aging populace, increasing disease rates, and technological advancements highlights the complex and evolving risk factors associated with PAD in the U.S. healthcare market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Artery Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Artery Disease Market Segments Analysis

Global Peripheral Artery Disease Market is segmented by Type, Treatment, Disease, Route of Administration, End User and region. Based on Type, the market is segmented into Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters, Hemodynamic Flow Alteration Devices, Inferior Vena Cava (IVC) Filters and Peripheral Accessories. Based on Treatment, the market is segmented into Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Others. Based on Disease, the market is segmented into Lipid Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs,, Inotropes,, Thrombolytic Agents, and Anti-Inflammatory Agents. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Artery Disease Market

The rising prevalence of elderly individuals affected by diabetes and hypertension is a crucial driving force behind the growth of the peripheral artery disease (PAD) market. Older adults are especially vulnerable to vascular complications, and the presence of these chronic conditions significantly heightens the risk of developing PAD. Diabetes and high blood pressure contribute to the narrowing and hardening of arteries, which severely restricts blood flow to the limbs. As a result, the increasing incidence of these health issues within the aging population is directly influencing market dynamics and creating a heightened demand for effective PAD treatments and interventions.

Restraints in the Peripheral Artery Disease Market

The recurring nature of peripheral artery disease (PAD) poses a significant challenge to the market's growth potential. Despite improvements in treatment options, the risk of PAD reappearing continues to hinder sustained market progression. Additionally, issues surrounding product recalls in the industry may further exacerbate these challenges. Such recalls can undermine consumer confidence, draw regulatory attention, and necessitate remedial actions, all of which can stifle overall market growth and stability. To effectively navigate these obstacles, stakeholders must collaboratively address the intricate issues related to managing the disease and ensuring product safety, thereby fostering ongoing advancements in solutions for peripheral artery disease.

Market Trends of the Peripheral Artery Disease Market

The Peripheral Artery Disease (PAD) market is witnessing a notable upward trend driven by the rising incidence of the condition alongside an influx of innovative product approvals. This surge in PAD cases underscores the demand for advanced diagnostic and therapeutic options, catalyzing market growth. The ongoing advancements in medical technologies are paving the way for new solutions that address the multifaceted challenges of PAD, enhancing patient care and outcomes. Furthermore, as regulatory bodies continue to endorse groundbreaking treatments, the market is expected to capitalize on these developments, fostering a landscape rich in opportunities for stakeholders and healthcare providers alike.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Peripheral Artery Disease Market Size by Type & CAGR (2026-2033)

• Market Overview
• Peripheral Angioplasty Balloons
• Plaque Modification Devices
• Peripheral Stents
• Peripheral Catheters
• Hemodynamic Flow Alteration Devices
• Inferior Vena Cava (IVC) Filters
• Peripheral Accessories

Global Peripheral Artery Disease Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Device
  • Stents
  • Balloons
  • Atherectomy Devices
• Catheters
  • Drug-Eluting Catheters
  • Balloon Catheters
  • Guidewires
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Others

Global Peripheral Artery Disease Market Size by Disease & CAGR (2026-2033)

• Market Overview
• Lipid Lowering Drugs
• Triple-H Therapy
• Glucose Regulating Drugs
• Blood Clot Preventing Drugs,
• Inotropes,
• Thrombolytic Agents,
• Anti-Inflammatory Agents

Global Peripheral Artery Disease Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Parenteral
• Others

Global Peripheral Artery Disease Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Clinics

Global Peripheral Artery Disease Market Size & CAGR (2026-2033)

• North America (Type, Treatment, Disease, Route of Administration, End User)
  • US
  • Canada
• Europe (Type, Treatment, Disease, Route of Administration, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Disease, Route of Administration, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Disease, Route of Administration, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Disease, Route of Administration, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations